Zedrick Aguirre

ORCID

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 9

Top Venues

Current medical research and opinion

This page only lists publications with an associated author ORCID identifier.

Publications

Frederick Berro Rivera, Eloise Arias-Aguirre, Zedrick Aguirre, Mc John C Ybañez, Janos Marc M Rubia, Danica Janine Galang, Grace Nooriza Lumbang, Jade Monica Marie J Ruyeras, John Vincent Magalong, Polyn Luz Pine, John Andrew C Amigo, Marie Francesca M Ansay, Nenad Zelenkov, Steve Samuel Thomas, Krishnaswami Vijayaraghavan
Evaluating the safety profile of semaglutide: an updated meta-analysis. Current medical research and opinion (2024)
Frederick Berro Rivera, Sung Whoy Cha, John Vincent Magalong, Nathan Ross B Bantayan, Linnaeus Louisse A Cruz, Eloise Arias-Aguirre, Zedrick Aguirre, Michelle Capahi Varona, Elaiza Marie Fernandez Co, Grace Nooriza Opay Lumbang, Byambaa Enkhmaa
Safety profile of proprotein convertase subtilisin/kexin type 9 inhibitors alirocumab and evolocumab: an updated meta-analysis and meta-regression. Current medical research and opinion (2024)
Frederick Berro Rivera, Eloise Arias-Aguirre, Zedrick Aguirre, Mc John C Ybañez, Janos Marc M Rubia, Danica Janine Galang, Grace Nooriza Lumbang, Jade Monica Marie J Ruyeras, John Vincent Magalong, Polyn Luz Pine, John Andrew C Amigo, Marie Francesca M Ansay, Nenad Zelenkov, Steve Samuel Thomas, Krishnaswami Vijayaraghavan
Evaluating the safety profile of semaglutide: an updated meta-analysis. Current medical research and opinion 40 (9) (2024)
Frederick Berro Rivera, Sung Whoy Cha, John Vincent Magalong, Nathan Ross B Bantayan, Linnaeus Louisse A Cruz, Eloise Arias-Aguirre, Zedrick Aguirre, Michelle Capahi Varona, Elaiza Marie Fernandez Co, Grace Nooriza Opay Lumbang, Byambaa Enkhmaa
Safety profile of proprotein convertase subtilisin/kexin type 9 inhibitors alirocumab and evolocumab: an updated meta-analysis and meta-regression. Current medical research and opinion 40 (7) (2024)
Frederick Berro Rivera, Sung Whoy Cha, John Vincent Magalong, Nathan Ross B Bantayan, Linnaeus Louisse A Cruz, Eloise Arias-Aguirre, Zedrick Aguirre, Michelle Capahi Varona, Elaiza Marie Fernandez Co, Grace Nooriza Opay Lumbang, Byambaa Enkhmaa
Safety profile of proprotein convertase subtilisin/kexin type 9 inhibitors alirocumab and evolocumab: an updated meta-analysis and meta-regression. Current medical research and opinion (2024)
Frederick Berro Rivera, Eloise Arias-Aguirre, Zedrick Aguirre, Mc John C Ybañez, Janos Marc M Rubia, Danica Janine Galang, Grace Nooriza Lumbang, Jade Monica Marie J Ruyeras, John Vincent Magalong, Polyn Luz Pine, John Andrew C Amigo, Marie Francesca M Ansay, Nenad Zelenkov, Steve Samuel Thomas, Krishnaswami Vijayaraghavan
Evaluating the safety profile of semaglutide: an updated meta-analysis. Current medical research and opinion (2024)
Frederick Berro Rivera, Eloise Arias-Aguirre, Zedrick Aguirre, Mc John C Ybañez, Janos Marc M Rubia, Danica Janine Galang, Grace Nooriza Lumbang, Jade Monica Marie J Ruyeras, John Vincent Magalong, Polyn Luz Pine, John Andrew C Amigo, Marie Francesca M Ansay, Nenad Zelenkov, Steve Samuel Thomas, Krishnaswami Vijayaraghavan
Evaluating the safety profile of semaglutide: an updated meta-analysis. Current medical research and opinion 40 (9) (2024)
Frederick Berro Rivera, Eloise Arias-Aguirre, Zedrick Aguirre, Mc John C Ybañez, Janos Marc M Rubia, Danica Janine Galang, Grace Nooriza Lumbang, Jade Monica Marie J Ruyeras, John Vincent Magalong, Polyn Luz Pine, John Andrew C Amigo, Marie Francesca M Ansay, Nenad Zelenkov, Steve Samuel Thomas, Krishnaswami Vijayaraghavan
Evaluating the safety profile of semaglutide: an updated meta-analysis. Current medical research and opinion (2024)
Frederick Berro Rivera, Sung Whoy Cha, John Vincent Magalong, Nathan Ross B Bantayan, Linnaeus Louisse A Cruz, Eloise Arias-Aguirre, Zedrick Aguirre, Michelle Capahi Varona, Elaiza Marie Fernandez Co, Grace Nooriza Opay Lumbang, Byambaa Enkhmaa
Safety profile of proprotein convertase subtilisin/kexin type 9 inhibitors alirocumab and evolocumab: an updated meta-analysis and meta-regression. Current medical research and opinion 40 (7) (2024)

Zedrick Aguirre.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Zedrick Aguirre